BAMEG_3697 is synthesized using recombinant DNA technology:
Expression: Cloned into plasmid vectors and expressed in E. coli, leveraging its robust protein production capacity .
Purification: Affinity chromatography via His-tag binding, followed by lyophilization for long-term storage .
Handling: Reconstituted in sterile water or PBS, with recommendations to avoid repeated freeze-thaw cycles .
This recombinant protein serves as a tool in anthrax-related studies:
While not directly tested in anthrax vaccine formulations, analogous spore/exosporium proteins (e.g., BclA, BxpB) enhance protection when combined with protective antigen (PA) . BAMEG_3697’s membrane localization suggests potential as a candidate for targeting B. anthracis surface antigens.
Commercially available as an antigen for generating polyclonal/monoclonal antibodies, enabling immunoassays (e.g., ELISA) .
| Application | Details | Source |
|---|---|---|
| ELISA Antigen | 50 µg quantities available; detects anti-BAMEG_3697 antibodies | |
| Structural Studies | Used in X-ray crystallography or cryo-EM to elucidate membrane interactions |
Though BAMEG_3697’s precise role remains uncharacterized, its classification as a membrane protein aligns with known B. anthracis virulence mechanisms:
S-Layer Proteins: B. anthracis employs S-layer-associated proteins (e.g., Sap, EA1) for adhesion and immune evasion . While BAMEG_3697 is not an S-layer component, its membrane localization may intersect with similar pathways.
Spore Proteins: Exosporium proteins (e.g., BclA) mediate phagocytic evasion . BAMEG_3697’s potential role in spore coat or germination processes warrants further investigation.
Functional Characterization: Determine interactions with B. anthracis virulence factors (e.g., toxin secretion, capsule formation).
Immunogenicity Studies: Assess antibody-mediated phagocytosis or germination inhibition in in vitro models .
Structural Biology: Resolve its 3D structure to identify binding interfaces for therapeutic targeting.
KEGG: bah:BAMEG_3697
BAMEG_3697 is a UPF0754 family membrane protein from Bacillus anthracis with 378 amino acids. It has the UniProt ID C3LE57 and is classified as a membrane protein based on its sequence characteristics . Analysis of its amino acid sequence reveals multiple hydrophobic regions consistent with transmembrane domains, particularly evident in the sequence "MNIWLSMLTTTGLGAIIGGFTNHLAIKMLFRPHRP" at the N-terminus and "LGGMIGIVQGLLLLFLK" at the C-terminus .
For determining cellular localization experimentally, researchers should consider:
Membrane fractionation followed by Western blotting using anti-His antibodies for the recombinant protein
Immunofluorescence microscopy with antibodies against the native protein or tag
GFP-fusion protein expression for live-cell imaging
Protease protection assays to determine membrane topology, similar to methods described for other membrane proteins
The hydrophobicity profile of BAMEG_3697 suggests multiple transmembrane regions, indicating it likely spans the bacterial membrane multiple times rather than being a peripheral membrane protein.
When expressing BAMEG_3697 in E. coli, codon optimization may be beneficial to account for the different codon usage between Bacillus and E. coli. The existing protocols have successfully yielded protein of greater than 90% purity as determined by SDS-PAGE .
The purification of recombinant BAMEG_3697 requires careful consideration of its membrane protein nature. Based on available information and general membrane protein purification principles:
Solubilization: Begin with appropriate detergent screening to solubilize BAMEG_3697 from membranes. Common detergents include:
n-Dodecyl β-D-maltoside (DDM)
n-Octyl β-D-glucopyranoside (OG)
Digitonin
CHAPS
Affinity Chromatography: Utilize the N-terminal His tag for initial purification via Immobilized Metal Affinity Chromatography (IMAC)
Begin with Ni-NTA resin
Use increasing imidazole concentrations for washing and elution
Consider using low concentrations of detergent in all buffers to maintain protein solubility
Additional Purification Steps:
Size Exclusion Chromatography (SEC) to separate monomeric from aggregated protein
Ion Exchange Chromatography for further purification if needed
Quality Control:
For researchers working with the commercially available recombinant protein, it comes as a lyophilized powder and should be reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL, with the addition of 5-50% glycerol for long-term storage .
Proper storage of recombinant BAMEG_3697 is crucial for maintaining its structural integrity and functional activity. According to the product information:
Short-term storage:
Long-term storage:
Reconstitution procedure:
Stability considerations:
Researchers should perform activity assays after storage to verify that the protein has maintained its functional properties, especially when designing experiments to characterize its biological function.
Comprehensive characterization of recombinant BAMEG_3697 requires multiple complementary analytical approaches:
Biochemical Characterization:
SDS-PAGE for purity assessment and molecular weight determination (~42 kDa expected)
Western blotting with anti-His antibodies for identity confirmation
Circular Dichroism (CD) spectroscopy for secondary structure analysis
Thermal shift assays to evaluate stability
Structural Analysis:
Crystallography trials (challenging for membrane proteins)
Cryo-electron microscopy for 3D structure determination
NMR spectroscopy for dynamic structural information
Computational modeling based on the amino acid sequence: "MNIWLSMLTTTGLGAIIGGFTNHLAIKMLFRPHRPMYIGKFQVPFTPGLIPKRRDELAVQLGKMVVEHLLTPEGIGKKLTNEEFQKGLIHWAQVEVDKVITNEQSLRHMLGKWDVAHVEKEATEKIEQVITEKIQAFLEEYYTYTWEQALPHSVHEKIENAIPNVSAFILKRAIHFFESEEGKSRLSRMIDDFFASRGALLNLVGMFLGNVSVVDRVQPEVIKFLGQDGTKQLLTDVLQKEWEKLKGRDVKELETFVEKEMIVSSILSAVKVEETVSKFLNQSVQQVCEPVRETIIEKVVPNAVTKGLKWGGENVESILNNLHLAEIVQQEVSTFSTERLEDLVLSITKNELKMITYLGALLGGMIGIVQGLLLLFLK"
Membrane Topology Analysis:
Mass Spectrometry Applications:
Intact mass analysis to confirm sequence integrity
Peptide mapping after protease digestion
Hydrogen-deuterium exchange (HDX) for accessible regions
Cross-linking MS for interaction studies
Combining these approaches will provide complementary information about the structural and biochemical properties of BAMEG_3697, essential for understanding its function in Bacillus anthracis.
Determining the membrane topology of BAMEG_3697 is crucial for understanding its function and interaction with other cellular components. Several complementary approaches can be employed:
Computational Prediction and Analysis:
Hydrophobicity analysis of the amino acid sequence suggests multiple transmembrane regions
Transmembrane prediction algorithms (TMHMM, HMMTOP, PHDhtm)
Signal peptide prediction tools to identify potential cleavage sites
Positive-inside rule application for loop orientation prediction
Experimental Approaches:
Protease Protection Assays: As described in search result , this technique allows for mapping the soluble domains of integral membrane proteins
a. Isolate membrane fractions containing BAMEG_3697
b. Treat with proteinase K under controlled conditions
c. Analyze protected fragments using mass spectrometry
d. Compare results between intact and disrupted membranes (high-pH treatment)
Cysteine Scanning Mutagenesis:
a. Create a cysteine-less version of BAMEG_3697
b. Introduce single cysteines at various positions
c. Test accessibility using membrane-permeable and -impermeable thiol-reactive reagents
d. Map accessible and inaccessible regions to determine topology
Fluorescence-Based Methods:
a. GFP-fusion reporters at different predicted loop regions
b. pH-sensitive fluorescent proteins to determine lumen vs. cytoplasmic localization
c. FRET-based distance measurements between domains
Combined Structural Methods:
Cryo-electron microscopy of membrane-embedded protein
X-ray crystallography of detergent-solubilized protein
Solid-state NMR for membrane-embedded structural determination
These approaches together can create a comprehensive topological map of BAMEG_3697, revealing which domains face the cytoplasm versus the periplasm/extracellular space, and how many times the protein traverses the membrane.
Post-translational modifications (PTMs) can significantly impact protein function and are particularly relevant for bacterial membrane proteins in pathogenesis. To identify and characterize PTMs in BAMEG_3697:
Mass Spectrometry-Based Approaches:
Bottom-up Proteomics:
a. Digest protein with multiple proteases (trypsin, chymotrypsin, proteinase K)
b. Analyze resulting peptides by LC-MS/MS
c. Search for mass shifts indicating modifications
d. Use neutral loss scanning for specific modifications (e.g., phosphorylation)
Top-down Proteomics:
a. Analyze intact protein by high-resolution MS
b. Determine exact mass and compare to theoretical
c. Fragment intact protein in MS (ECD/ETD) to localize modifications
Targeted Analysis:
a. Multiple Reaction Monitoring (MRM) for known modifications
b. Parallel Reaction Monitoring (PRM) for improved specificity
c. SWATH-MS for comprehensive modification scanning
Enrichment Strategies for Specific PTMs:
Phosphorylation: IMAC (Fe³⁺, Ti⁴⁺, Ga³⁺), titanium dioxide, phospho-antibodies
Glycosylation: Lectin affinity, hydrazide chemistry, HILIC
Lipidation: Click chemistry for fatty acid modifications
Methylation/acetylation: Specific antibodies, SILAC labeling
Functional Validation of PTMs:
Site-directed mutagenesis of modified residues
Functional assays comparing wild-type and mutant proteins
In vitro modification with purified enzymes
Inhibitor studies targeting specific modification enzymes
A table summarizing potential PTMs in bacterial membrane proteins and their detection methods:
| PTM Type | Common Sites | Detection Methods | Functional Significance |
|---|---|---|---|
| Phosphorylation | Ser, Thr, Tyr | TiO₂ enrichment, Phospho-antibodies, Neutral loss MS | Signaling, regulation |
| Methylation | Lys, Arg, Glu | Antibodies, MS with high resolution | Protein-protein interactions |
| Acetylation | Lys, N-terminus | Antibodies, MS/MS fragmentation | Stability, localization |
| Lipidation | Cys, N-terminus | Click chemistry, hydrophobic fractionation | Membrane anchoring |
| Glycosylation | Asn, Ser, Thr | Lectin affinity, oxonium ions in MS | Cell recognition, stability |
Given the overlapping peptides produced from digestion with proteinase K as mentioned in search result , this approach would be particularly suitable for identifying phosphorylation and methylation sites on BAMEG_3697.
Investigating protein-protein interactions of membrane proteins like BAMEG_3697 presents unique challenges but is crucial for understanding their biological functions. Several complementary approaches can be employed:
Affinity-Based Methods:
Co-immunoprecipitation (Co-IP):
a. Use anti-His antibodies to pull down recombinant BAMEG_3697
b. Identify co-precipitating proteins by MS or Western blotting
c. Perform reciprocal Co-IP to confirm interactions
d. Consider crosslinking prior to lysis to capture transient interactions
Pull-down Assays:
a. Immobilize purified BAMEG_3697 on Ni-NTA or other affinity resin
b. Incubate with bacterial lysate or purified candidate interactors
c. Wash and elute complexes for analysis
Proximity-Dependent Labeling:
a. BioID or TurboID fusion to BAMEG_3697
b. Express in B. anthracis or reconstituted system
c. Identify biotinylated proximity partners by MS
Biophysical and Structural Methods:
Surface Plasmon Resonance (SPR):
a. Immobilize BAMEG_3697 on sensor chip
b. Measure real-time binding kinetics with potential partners
c. Determine binding affinities and kinetic parameters
Microscale Thermophoresis (MST):
a. Label BAMEG_3697 with fluorescent dye
b. Measure changes in thermophoretic mobility upon binding
c. Determine Kd values in solution
Cryo-EM and X-ray Crystallography:
a. Obtain structural information of protein complexes
b. Identify binding interfaces and structural changes upon interaction
Genetic and In Vivo Approaches:
Bacterial Two-Hybrid:
a. Fuse BAMEG_3697 to DNA-binding domain
b. Screen against prey library fused to activation domain
c. Identify positive interactions through reporter activation
Split GFP/Luciferase Complementation:
a. Fuse fragments to BAMEG_3697 and candidate interactors
b. Express in bacterial system
c. Measure complementation signal indicating proximity
Computational Prediction:
Homology-based interaction prediction
Co-evolution analysis to identify potential binding partners
Molecular docking simulations with candidate interactors
When designing these experiments, it's important to maintain the membrane environment or use appropriate detergents to preserve native protein conformation and interaction capability. The methods described for proteomic analysis of membrane proteins in search result could be adapted for studying BAMEG_3697 interactions, particularly the approach that preserves the lipid bilayer structure.
Comparative analysis of BAMEG_3697 with homologous proteins can provide valuable insights into its evolutionary conservation, functional importance, and potential roles in Bacillus anthracis biology. A systematic approach includes:
Sequence-Based Comparative Analysis:
Homology Identification:
a. BLAST/PSI-BLAST searches against bacterial protein databases
b. HMM-based searches using HMMER to identify distant homologs
c. Focus on both pathogenic and non-pathogenic bacterial species
Multiple Sequence Alignment:
a. Align BAMEG_3697 with homologs using tools like MUSCLE, MAFFT, or T-Coffee
b. Identify conserved motifs and residues
c. Map conservation onto predicted transmembrane topology
Phylogenetic Analysis:
a. Construct phylogenetic trees to understand evolutionary relationships
b. Correlate with bacterial species phylogeny
c. Identify potential horizontal gene transfer events
Structural Comparison:
3D Structure Prediction:
a. Use AlphaFold2 or RoseTTAFold for BAMEG_3697 and homologs
b. Compare predicted structures to identify conserved structural elements
c. Focus on membrane-spanning regions and potential functional domains
Domain Architecture Analysis:
a. Identify protein domains using tools like InterPro and Pfam
b. Compare domain composition across homologs
c. Identify unique domains in BAMEG_3697 vs. homologs
Functional Comparative Analysis:
Genomic Context:
a. Examine neighboring genes in B. anthracis and related species
b. Identify potential operons and functional associations
c. Compare gene neighborhood conservation across species
Expression Pattern Comparison:
a. Analyze expression data for BAMEG_3697 and homologs
b. Identify conditions triggering expression
c. Compare regulation mechanisms across species
Experimental Functional Substitution:
a. Express BAMEG_3697 in species with deleted homologs
b. Test functional complementation
c. Identify species-specific vs. conserved functions
| Species | Protein ID | Sequence Identity (%) | Predicted Function | Genomic Context | Conservation of Key Motifs |
|---|---|---|---|---|---|
| B. cereus | - | ~85-95% (estimated) | UPF0754 family membrane protein | Similar to B. anthracis | High |
| B. thuringiensis | - | ~80-90% (estimated) | UPF0754 family membrane protein | Similar to B. anthracis | High |
| B. subtilis | - | ~60-70% (estimated) | UPF0754 family membrane protein | May differ | Moderate |
| S. aureus | - | ~30-40% (estimated) | Membrane protein | Different | Low-Moderate |
| E. coli | - | ~20-30% (estimated) | Unknown | Different | Low |
Note: The percentages and specific homologs are estimated and would need to be determined through actual sequence analysis, as specific homology information was not provided in the search results.
Functional characterization of a membrane protein with unknown function like BAMEG_3697 requires carefully designed experimental conditions. Based on its properties as a membrane protein from Bacillus anthracis, the following approaches are recommended:
Reconstitution Systems:
Proteoliposomes:
a. Purify BAMEG_3697 using methods described earlier
b. Test different lipid compositions mimicking B. anthracis membrane
c. Optimize protein:lipid ratios (typically 1:100 to 1:1000)
d. Verify correct orientation using protease protection assays
Nanodiscs:
a. Incorporate BAMEG_3697 into nanodiscs with MSP proteins
b. Provide native-like membrane environment with defined size
c. Optimize MSP:protein:lipid ratios for stability
d. Confirm incorporation by size exclusion chromatography
Detergent Micelles:
a. Screen detergents for optimal stability (DDM, LMNG, etc.)
b. Monitor protein stability using thermal shift assays
c. Optimize detergent concentration above CMC
Functional Assays Based on Predicted Properties:
Transport Assays (if suspected to be a transporter):
a. Fluorescent substrate uptake measurements
b. Counterflow assays with radiolabeled substrates
c. Liposome swelling assays for channel activity
Enzyme Activity Assays (if suspected to have enzymatic function):
a. Screen potential substrates based on sequence analysis
b. Develop coupled enzyme assays for activity detection
c. Test pH, temperature, and ion dependencies
Binding Assays (if suspected to be a receptor):
a. Screen potential ligands using thermal shift assays
b. Measure binding affinities using ITC, SPR, or fluorescence-based methods
c. Perform competition binding assays to identify specific binding sites
Genetic and Cell-Based Approaches:
Gene Knockout/Knockdown:
a. Generate BAMEG_3697 deletion mutants in B. anthracis
b. Characterize phenotypic changes (growth, morphology, stress response)
c. Perform complementation studies with wild-type and mutant variants
Overexpression Effects:
a. Analyze consequences of BAMEG_3697 overexpression
b. Monitor changes in membrane properties and cellular physiology
c. Identify potential toxic effects indicating function
Reporter Fusion Assays:
a. Generate transcriptional and translational fusions
b. Identify conditions affecting expression
c. Map regulatory networks controlling BAMEG_3697
Buffer and Environmental Conditions:
pH range: Test pH 6.0-8.0 (physiological range for B. anthracis)
Temperature: 25-37°C (optimal growth temperature for B. anthracis)
Salt concentration: 100-300 mM NaCl
Additional components: Mg²⁺, Ca²⁺, and other physiologically relevant ions
Reducing conditions: Include DTT or β-mercaptoethanol if cysteine residues are present
For storage and handling of the recombinant protein, follow the recommendations provided earlier: store at -20°C/-80°C with glycerol as a cryoprotectant, and avoid repeated freeze-thaw cycles .